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Abstract
Care of stroke patients costs considerably more in specialized stroke units (SU) compared to care in general medical
wards (GMW) but the technology may be cost effective if it leads to significantly improved outcomes. While
randomized control trials show better outcomes for stroke patients admitted to SU, observational studies report
mixed findings. In this paper we use individual level data from first-ever stroke patients in four European cities and find
evidence of selection by the initial severity of stroke into SU in some cities. In these cases, the impact of admission to
SU on outcomes is overestimated by multivariate logit models even after controlling for case-mix. However, when the
imbalance in patient characteristics and severity of stroke by admission to SU and GMW is adjusted using propensity
score methods, the differences in outcomes are no longer statistically significant in most cases. Our analysis explains
why earlier studies using observational data have found mixed results on the benefits of admission to SU.
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Background
European health care systems have significant differences
among them but a common feature is to typically rely
on a coordinated or centrally planned decision about the
adoption of new technologies and services. In that respect,
cost-effectiveness analysis plays an important role in this
decision. For instance, in the U.K., the National Institutes
of Clinical Excellence (NICE) recommends that a new
technology be adopted if the cost per quality adjust life
year (QALY) is £30,000 or less. However, analysis based
on observational data, as opposed to randomized control
trials, may reach different conclusions about the relative
effectiveness (or cost effectiveness) of a new service. In
part this may be due to selective assignment of patients to
new technologies or services relative to the standard care
in different centers.
In this paper we use observational data on patient
outcomes from four European cities on stroke patients
who are exposed to an expensive technology – admis-
sion to a specialized stroke unit ward (SU) or general
medical wards (GMW), and demonstrate the importance
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of correcting for selection bias in measuring differences
in outcomes (which in turn are used in calculations of
incremental cost effectiveness ratios). We find evidence
of overt selection into SU in some cities, and, in these
cases, find that the impact of admission to SU on out-
comes is overestimated by standard multivariate logit
models even after controlling for case-mix. Using propen-
sity score methods to control for selection, we do not
find evidence of differential outcomes by admission to SU
or other wards. Our analysis explains why earlier studies
using observational data have found mixed results on the
benefits of admission to SU.
Selection bias is said to occur when patients with spe-
cific characteristics are systematically assigned to treat-
ment A or B and these characteristics independently
also influence the outcome. Reasons for such selections
may stem from a de facto policy of admitting patients
with given risk factors into the more intensive treat-
ment group [1]. Alternatively, physicians’ aversion to risk
may lead to higher risk patients receiving more con-
servative care [2,3]. For instance, in interventions for
cardiovascular disease, older and high risk patients with
chronic kidney disease are often treated more conserva-
tively despite the fact that these higher risk patients may
receive greater benefit from coronary angiography after
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acute myocardial infarction [2]. Similarly, Dranove et al.
showed that publication of ‘report cards’ on health care
providers in New York and Pennsylvania led to selection
behavior where both doctors and hospitals preferred to
treat healthier patients for coronary artery bypass graft
(CABG) surgery, which in turn decreased patient and
social welfare [3]. In observational studies, overt selection
bias occurs when there is an imbalance in the charac-
teristics of patients assigned to the treatment or con-
trol groups and these characteristics also influence the
outcome [4,5].
In the context of admission to stroke unit, this can hap-
pen if patients with certain characteristics, e.g., type of
stroke, severity, age, pre-existing conditions, are either
systematically admitted to stroke units or admitted to
other wards since these characteristics also independently
influence patient outcome. The bias may be favorable in
one center (healthier stroke patients admitted to stroke
unit in one city), unfavorable in another (triaging those
with worse case-mix into stroke units) and yet may not
be present in other cases. Similarly, hidden or covert bias
can occur if patients in treatment or control groups dif-
fer in unobservables and these differences also influence
outcomes.
Regardless of the reasons for selection bias – gam-
ing, triaging, defacto policies or constraints of the health
care system – estimation methods that do not explicitly
account for these differences lead to biased estimates of
the treatment effect [6-8]. Traditional case-mix adjust-
ments via multivariate regression based methods cannot
completely account for the selection bias. In the pres-
ence of overt bias, propensity score methods have been
proposed as alternatives for estimating treatment effect.
Under this method, one first computes the probability
that a patient is assigned to treatment or control group
conditional on the observed characteristics, and then con-
ditional on this score, compares outcomes between the
two groups [5,9,10]. Rosenbaum and Rubin showed that
under the assumption of strongly ignorable treatment
assignment, given the observed covariates, selection bias
generated by the differences in observed covariate values
between the two groups can be removed [4]. Nonethe-
less, in a systematic review of 43 studies, Shah et al.
concluded that regressions and propensity score methods
gave similar results, but also found that odds or hazard
ratios computed using propensity score methods were, on
average, 6.4% of the times closer to one compared to tra-
ditional regression based methods, and that the statistical
significance across the twomethods differed in only about
10% of the cases [11]. Similarly, Stürmer et al. report that
in only 9 of 69 studies, the effect estimate differed by more
than 20% across the two methods [12].
In the present study, we compare outcomes for stroke
patients admitted to specialist stroke units (SU) and other
general medical wards (GMW) from four different cities
in Europe. We pay particular attention to the issue of
selection bias and explicitly model the likelihood of a
patient being admitted to SU given their case-mix, and
importantly, the measured severity of stroke prior to
admission to SU or GMW. We use both the regression
based and propensity score based methods and highlight
the differences in estimated treatment effects across these
methods. Pooling observations from multiple centers cre-
ates the added difficulty of appropriately accounting for
heterogeneity of services in SU across centers. Thus, to
account for heterogeneity of services in SU across the
four centers, as well as to allow for possibly different
forms of selection bias (favorable, unfavorable or none),
we analyze data from each of the four cities separately.
This then allows us to detect selection and account for
it when comparing outcomes in SU versus GMW within
each city rather than confound the results by compar-
ing across non-homogeneous SU centers. For comparison,
we also show results from pooling all observations across
centers and ignoring the underlying heterogeneity across
centers.
Methods
Source, sample and variables
Data for this study are drawn from the European Register
of Stroke Collaborators (EROS) database and is a col-
lection of population based registers established in six
European cities including Dijon (France), Sesto Fiorentino
(Italy), Kaunas (Lithuania), Warsaw (Poland), Mahon,
Menorca (Spain) and London (UK). The database has
been described in detail elsewhere and we restrict our
description to the selected sample for this study [13,14].
The data collection took place between 2004 and 2006
and provides detailed information on 2,127 first-ever
stroke patients from an estimated 2005 source population
of 1,087,048. The database includes patient information
on demography, comorbidities, living conditions prior to
stroke, severity and type of stroke, whether the patient
was admitted to a hospital, type of hospital ward admit-
ted to, length of stay, and types and counts of services and
therapies provided to the patient. Patients were followed
for up to one year in all centers (with some centers fol-
lowing patients for two years) and consequently mortality
outcome is known.
The three main outcome measures were mortality at
one month, three months and one year and are analyzed
by whether a patient is admitted to SU or GMW. Two
centers, Warsaw and Menorca, were omitted from this
analysis due to lack of variation in type of admission (SU
or GMW). In Warsaw, all but four patients were admitted
to SU, while in Menorca only one patient was admit-
ted to SU. Within each center we restricted our attention
to patients who either suffered cerebral infarction (CI)
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or primary intracerebral haemorrhage (PICH), as these
patients would be typically eligible for SU care. Among
the remaining four centers, 35 patients were not admit-
ted to any hospital, the type of ward is not known for four
patients, 49 patients had a subarachnoid haemorrhage
(SAH), and 42 had an unknown or unclassified type of
stroke. This led to an exclusion of 128 observations (there
was some overlap) giving a potential sample of 1,693 first-
ever stroke patients with either first-time stroke as CI or
PICH. The final sample consisted of 1,492 observations,
where the additional loss of observations was because
complete information on case-mix variables (described
below) was not available.
Severity of stroke at initial diagnosis is measured using
two alternative scales, the Glasgow Coma Scale (GCS) and
the National Institutes of Health Stroke Scale (NIHSS)
[14]. Glasgow Coma Scale is a neurological scale that
measures the conscious state of a patient and is used
for both initial as well as subsequent assessment. The
scale consists of a sum of numerical scores assigned to
three components that test for eye, verbal and motor
responses (assigned from 1–4 or 1–6 for different com-
ponents) where the lowest possible value of 3 for GCS
means deep coma or death while the highest value of
15 implies a fully awake person. Our primary analysis
uses GCS as a measure of severity of stroke because it
is available in our data set for all patients (at the time
of admission) whereas the NIHSS (an alternative scale)
is not recorded for about 25% of our working sample
and hence serves as a secondary measure for robustness
checks. In our sensitivity analysis we also used alterna-
tive forms of the GCS variable. For instance, rather than
use the value of GCS, we used individual components
of GCS by eye movement, motor movement and verbal
component scores, and also repeated the analysis treat-
ing GCS as a categorical variable (low, medium and high).
Several other variants of the model were also estimated
and results from those are discussed in the Robustness
section.
Other relevant controls include age, age square, gen-
der, interaction of age and gender, type of stroke (CI or
PICH), swallowing test, ability to lift both arms, abil-
ity to walk, pre-stroke comorbidities (Atrial Fibrillation
(AF), Myocardial Infarction (MI), DiabetesMellitus (DM),
Hypertension (HT)), whether the patient was indepen-
dent or needed assistance in the two weeks prior to stroke
and living conditions prior to stroke (home alone, home
with others, supportive living/nursing home, long term
hospital care, or other/unknown). This last variable, living
conditions prior to stroke, is not coded uniformly across
centers and hence we accordingly use only categories that
are available. For instance, in the case of London and
Dijon, patients are coded according to all five categories
but in the case of Florence all patients in the sample are
either coded as home alone or home with others. Data are
summarized in Table 1.
Table 1 Mean value of outcome and GCS scores by admission to SU and GMW
London Kaunas Dijon Florence
Combined
For all patients
Number of patients 365 699 335 93 1492
Mortality (30 days) 17% 15% 5% 13% 13%
Mortality (90 days) 21% 19% 8% 20% 17%
Mortality (365 days) 28% 25% 15% 24% 24%
Glasgow Coma Score (GCS) 12.79 13.72 14.51 13.43 13.65
For patients admitted to SU
Number of patients 292 77 132 33 534
Mortality (30 days) 12% 44% 4% 15% 15%
Mortality (90 days) 18% 56% 5% 24% 20%
Mortality (365 days) 25% 68% 10% 27% 27%
Glasgow Coma Score (GCS) 13.19 11.47 14.64 13.15 13.30
For patients admitted to GMW
Number of patients 73 622 203 60 958
Mortality (30 days) 36% 11% 5% 12% 12%
Mortality (90 days) 37% 14% 10% 18% 15%
Mortality (365 days) 43% 20% 18% 22% 21%
Glasgow Coma Score (GCS) 11.18 14.00 14.42 13.58 13.85
Abbreviations: Glasgow Coma Scale (GCS); Stroke Unit (SU); General Medical Ward (GMW).
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Analysis – multivariate logits
For each of the three outcome measures (mortality at 30,
90 and 365 days), multivariate logit models were estimated
to compute the odds ratio of mortality for admission to
SU relative to GMW by center, controlling for severity of
stroke and other relevant risk factors (i.e., demographic
and case-mix adjustments). Thus for each of the four cen-
ters and three outcomes (c = 1, 2, 3, 4 and o = 1, 2, 3) we
estimated,
Pr
(
Ycoi = 1
) =  (βco1 SUi + βco2 SSi + βco3 Xi
)
(1)
where SSi is a measure of severity of stroke at initial diag-
nosis (GCS or NIHSS), Xi is a vector of other relevant risk
factors (i.e., demographic and case-mix adjustments listed
earlier) for the ith patient and the primary coefficient of
interest is β1 which provides the odds ratio for admission
to SU (by center c and outcome o).
Additionally, for each center, we also estimated odds
ratio for admission to stroke unit as a function of sever-
ity of stroke. In this second model, the primary interest
is in detecting whether the severity of stroke (GCS or
NIHSS) predicts if a patient is admitted to SU or GMW,
after controlling for other observable characteristics of the
patients (case-mix, demographic variables, and other pre-
stroke conditions). Thus for each of the four centers, we
estimated
Pr
(
SUci = 1
) =  (θ c1SSi + θ c2Zi
)
(2)
where SSi is the measure of severity of stroke at initial
diagnosis, Zi is the vector of other controls, and θ1 is the
coefficient of interest which provides odds of admission
to SU as a function of severity of stroke. Results from
multivariate logits are summarized in Table 2.
Analysis - propensity score stratification and weighting
We checked for the imbalance in the values of the
observed characteristics for patients admitted to SU and
GMW using univariate measures of differences in means.
Large and significant differences were observed in many
covariates. Hence we re-estimated the logits for admission
to SU or GMW but also included interactions of variables
that were identified in the previous univariate analysis to
be significant. The predicted values from the logit, which
is the probability that a patient will be admitted to SU, was
then used as the propensity score for the patient in a given
center. Patients admitted to SU were assigned a weight
of the reciprocal of the predicted probability of admis-
sion to SU while those admitted to GMW were assigned
a weight of the reciprocal of the probability of admission
to GMW.Weighted differences in means between SU and
GMWwere then computed to test if the propensity scores
achieved reasonable balance among observables between
SU and GMW [2,4,8,9]. Weighted and un-weighted differ-
ences in the covariates are summarized in Tables 3.
Based on the propensity scores, two methods were used
to assess the impact of SU on outcomes. In the first
method, using observations on the common support, we
Table 2 Selected odds ratios (OR) and confidence intervals1
Outcome London Kaunas Dijon Florence
Combined
Panel A Unadjusted odds ratios for outcomes by admission to SU
Mortality (30 days) 0.25 [0.14,0.45] 6.34 [3.79,10.6] 0.69 [0.23,2.03] 1.35 [0.39,4.65] 1.29 [0.95,1.77]
Mortality (90 days) 0.36 [0.21,0.63] 7.78 [4.70,12.9] 0.44 [0.17,1.12] 1.43 [0.51,3.99] 1.42 [1.08,1.87]
Mortality (365 days) 0.44 [0.26,0.76] 8.35 [4.99,14.0] 0.51 [0.26,1.00] 1.36 [0.51,3.62] 1.39 [1.09,1.78]
Panel B Adjusted odds ratios for outcomes by admission to SU2
Mortality (30 days) 0.12 [0.03,0.46] 1.40 [0.69,2.84] 0.93 [0.17,4.91] 3.11 [0.16,59.1] 0.85 [0.53,1.36]
Mortality (90 days) 0.35 [0.11,1.11] 1.98 [0.99,3.97] 0.58 [0.17,2.00] 3.89 [0.30,50.7] 1.18 [0.79,1.78]
Mortality (365 days) 0.55 [0.23,1.29] 2.09 [1.07,4.06] 0.80 [0.34,1.90] 1.99 [0.33,11.9] 1.16 [0.83,1.63]
Panel C Adjusted odds ratios for outcomes by admission to SU3
Mortality (30 days) 0.02 [0.00,0.18] 2.85 [0.60,13.53] 1.09 [0.17,7.02] 76.9 [0.91,64754] 0.85 [0.43,1.67]
Mortality (90 days) 0.20 [0.04,0.94] 4.76 [1.09,20.71] 0.85 [0.20,3.66] 4.50 [0.14,147] 1.45 [0.82,2.55]
Mortality (365 days) 0.40 [0.14,1.18] 1.83 [0.51,6.57] 0.84 [0.31,2.32] 1.04 [0.11,9.88] 1.12 [0.72,1.74]
Panel D Adjusted odds ratios for admission to SU by GCS/NIHSS4
GCS 1.17 [1.06,1.28] 0.87 [0.79,0.95] 1.07 [0.87,1.32] 0.89 [0.75,1.06] 0.93 [0.89,0.98]
NIHSS 0.93 [0.88,0.98] 1.22 [1.05,1.42] 0.90 [0.83,0.97] 1.09 [1.00,1.89] 1.04 [1.01,1.07]
Note 1: Odds Ratio [95% C.I.] from logit estimates. C.I. based on robust standard errors.
Note 2: ORs from logit of Outcome on Admission to SU (controlling for GCS and other variables).
Note 3: ORs from logit of Outcome on Admission to SU (controlling for GCS, NIHSS and other variables).
Note 4: ORs from logit of Admission to SU by GCS and NIHSS (controlling for other variables).
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Table 3 Difference in casemix and patient characteristics by SU and GMW
London Kaunas Dijon Florence
Pre Post Pre Post Pre Post Pre Post
GCS 2.014a -0.157 -2.531a -0.416 0.225 -0.086 -0.432 -0.057
0.000 0.731 0.000 0.150 0.217 0.770 0.527 0.938
Swallow test -0.120c -0.035 0.123a 0.008 -0.185a -0.017 -0.071 -0.036
(1/0, 1 if fail) 0.058 0.668 0.007 0.913 0.000 0.765 0.458 0.701
Age 0.192 0.800 9.912a 3.327b -4.483a -0.796 -4.720c -0.676
0.917 0.714 0.000 0.050 0.003 0.612 0.063 0.769
Age square -66.163 131.689 1,398.868a 406.985c -579.525a -102.443 -616.334c -89.409
0.785 0.646 0.000 0.100 0.004 0.635 0.078 0.782
Male 0.041 -0.038 -0.117b 0.016 0.002 -0.003 0.073 -0.014
(1/0: 1 if true) 0.527 0.624 0.050 0.868 0.970 0.958 0.504 0.902
Age*Male 3.959 -1.331 -4.488 2.435 -1.957 -0.791 3.068 -1.349
0.389 0.791 0.279 0.699 0.636 0.864 0.698 0.871
Stroke type: CI 0.130a -0.021 -0.006 -0.009 -0.017 0.009 0.045 -0.010
(1/0: 1 if true) 0.006 0.659 0.866 0.847 0.549 0.742 0.563 0.911
Prestroke - AF -0.038 -0.005 0.168a 0.077 0.063 0.015 -0.065 -0.027
(1/0: 1 if true) 0.436 0.933 0.001 0.384 0.178 0.784 0.452 0.755
Prestroke - DM -0.045 -0.071 0.004 0.016 -0.006 -0.003 0.009 -0.004
(1/0: 1 if true) 0.416 0.355 0.911 0.821 0.892 0.944 0.922 0.964
Prestroke - HT 0.127b -0.049 -0.039 0.047 -0.044 -0.000 -0.105 -0.008
(1/0: 1 if true) 0.047 0.492 0.491 0.496 0.414 0.996 0.327 0.939
Prestroke - MI -0.010 -0.002 0.008 0.040 -0.049 -0.022 -0.062 -0.029
(1/0: 1 if true) 0.782 0.959 0.854 0.613 0.189 0.556 0.441 0.709
Needed help last 2wks -0.079 0.412 0.226a 0.711 -0.145a -0.132a -0.081 -0.014
(1/0: 1 if true) 0.123 0.318 0.000 0.176 0.001 0.001 0.355 0.888
Able to walk 0.043 -0.067 0.203a 0.115c
(1/0: 1 if true) 0.509 0.407 0.000 0.072
Lift both arms 0.108c 0.002 -0.463a -0.449a 0.079 -0.016
(1/0: 1 if true) 0.099 0.980 0.000 0.000 0.147 0.799
Home alone -0.000 0.014 0.109b 0.071 -0.069 0.000
(1/0: 1 if true) 1.000 0.855 0.018 0.323 0.192 0.995
Home w./ others 0.065 -0.040 -0.211a -0.075 0.054 0.014
(1/0: 1 if true) 0.320 0.616 0.000 0.315 0.336 0.820
Supportive living -0.086a 0.002 -0.019 -0.006
(1/0: 1 if true) 0.004 0.937 0.474 0.819
LT hospital care 0.010 0.009 -0.059b -0.009
(1/0: 1 if true) 0.593 0.569 0.017 0.805
Home unknown 0.010 0.015 0.103a 0.004 0.093a 0.001
(1/0: 1 if true) 0.593 0.112 0.000 0.827 0.008 0.971
Difference and p-value: Table provides difference (SU-GMW) in covariates (p-value listed below the difference).
Pre: Difference and p-value before adjusting by propensity score.
Post: Difference and p-value after applying weights based on propensity score.
Significance: Superscripts a, b, c indicate if p-value is less that .01, .05 and .10 respectively.
Abbreviations: Stroke Unit (SU); General Medical Ward (GMW); Glasgow Coma Scale (GCS); Cerebral Infarction (CI); Atrial Fibrillation (AF); Diabetes Mellitus (DM);
Hypertension (HT); Myocardial Infarction (MI); Long Term (LT).
stratified the observations based on the propensity score.
In the case of London and Kaunas, five strata were defined
(quintiles). For Dijon and Florence, observations were
divided into three strata. Dijon has a very low mortality
rate and hence division into five strata leads to zero mor-
tality in some of the subgroups, thus making computation
of odds ratio for the strata in question infeasible. Similarly,
there are relatively few observations available for Florence
(93 total) again making five strata infeasible. Hence for
these two centers, only three strata were used. Nonethe-
less, in each case, whether three or five strata were used,
the first two moments of the propensity score between SU
andGMWobservations were compared within each strata
to further check for adequacy of balance. Odds ratio of
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mortality for admission to SU were computed within each
strata and a weighted average across strata was derived
based on weights proportional to the inverse of the vari-
ance of the estimates [15]. In the second method, we com-
puted the odds ratios based solely on the weights assigned
to observations (reciprocal of probability for SU and recip-
rocal of one minus the probability for GMW) rather than
stratification by propensity scores. This method was used
to test for the robustness of the results implied by the
stratification method. The results from the two methods
(stratification or weighting) are given in Table 4 and are
listed as PSM1 and PSM2 respectively.
Results and discussion
Descriptive statistics
Relevant summary statistics are provided in Table 1. Of
the 1,492 patients, 13% died within 30 days. The over-
all rate was highest in London (17%) and lowest in Dijon
(5%). Across the four centers, 534 patients were admitted
to SU wards of which 15% died within one month, while
958 patients were admitted to GMWwards, of which 12%
died within one month. This higher 30 day mortality rate
in SU is driven mostly by one center, Kaunas, where 44%
of patients died in the SU while only 11% died in GMW.
The mortality rate in Florence in SU is also higher than in
GMW, but the difference is not statistically significant. In
the other two centers (London andDijon), the 30 daymor-
tality is always lower in SU though again the difference is
not statistically significant in the case of Djon. A similar
pattern exists for the other two outcome measures: com-
pared to GMW, mortality rates are lower in SU in London
and Dijon, but higher in SU in Kaunas and Florence and
not significantly different across SU or GMW inDijon and
Florence.
Overall 35.7% of the patients were admitted to SU (534
out of 1492). However, there is a significant imbalance
across centers. Admission to SU in Dijon is 35.5% and in
Florence it is 39.4%, but in London 80% of the patients
are admitted to SU while in Kaunas only 11% are admit-
ted to SU. Similarly, the mean value of GCS for patients
admitted to SU versus those admitted to GMW in both
Dijon and Florence are very close to each other (for exam-
ple in Florence the average values are 13.15 and 13.58
respectively) but there is a large difference in the mean
values of GCS in both London and Kaunas. In London,
the mean GCS value of patients admitted to SU is 2 points
higher than those in GWM (13.19 vs. 11.18) while for Kau-
nas the mean value of GCS for patients in SU is 2.5 points
lower than in GMW (11.47 vs 14).
Multivariate logit analysis
Panel A of Table 2 provides the unadjusted odds ratios
(OR) of mortality by admission to SU versus GMW. For
instance, the OR for 30 day mortality in London is 0.25
for patients admitted to SU relative to patients admitted
to GMW and the OR is statistically significantly different
from one. For each of the three outcomes, the unadjusted
odds ratios are significantly lower than one for London,
higher than one and significant for Kaunas, and lower than
one and higher than one for Dijon and Florence respec-
tively, but not statistically different from one for the latter
two cities. The last column provides ORs when the obser-
vations from the four centers are combined. The ORs for
the three outcomes are above one because the combined
data is dominated by large number of observations from
Kaunas where the overall mortality rates in SU are much
higher than in any other center.
Mortality odds ratios by admission to SU or GMW,
adjusted by severity of stroke as measured by GCS, patient
demographics and other case-mix variables listed earlier
are given in Panel B of Table 2. After controlling for these
factors, the mortality OR by admission to SU was signifi-
cantly lower than one for the 30 day mortality in London
but not significantly different from one for the 90 day or
one year mortality. For Kaunas, it continued to be above
one but was significant for only the one year mortality. For
Dijon and Florence, the 95% C.I. always included one in
the interval. Since the GCS can suffer from ceiling effect,
we repeated the analysis above using NIHSS as a measure
of severity of stroke. This reduced the working sample by
Table 4 Odds ratios and confidence intervals – propensity score adjusted
Outcome
London Kaunas Dijon Florence
Combined
Odds ratios for outcomes by admission to SU – PSMmethod 1
Mortality (30 days) 0.49 [0.25,0.99] 1.77 [0.98,3.19] 1.81 [0.42,7.88] 1.51 [0.39,5.82] 1.09 [0.78,1.51]
Mortality (90 days) 0.66 [0.34,1.29] 2.29 [1.29,4.07] 0.72 [0.25,2.08] 1.52 [0.48,4.81] 1.18 [0.88,1.58]
Mortality (365 days) 0.72 [0.39,1.35] 2.75 [1.50,5.04] 0.70 [0.33,1.46] 1.41 [0.49,4.10] 1.15 [0.88,1.49]
Odds ratios for outcomes by admission to SU – PSMmethod 2
Mortality (30 days) 0.55 [0.26,1.16] 1.37 [0.66,2.84] 2.11 [0.48,9.25] 1.24 [0.35,4.46] 0.94 [0.68,1.31]
Mortality (90 days) 0.75 [0.37,1.52] 2.42 [1.13,5.21] 0.82 [0.27,2.52] 1.28 [0.41,3.96] 1.06 [0.79,1.41]
Mortality (365 days) 0.74 [0.38,1.47] 2.16 [1.02,4.59] 0.76 [0.36,1.63] 1.23 [0.42,3.61] 1.06 [0.82,1.37]
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about 25% but other than the point differences in OR, it
resulted in qualitatively similar findings and are listed in
Panel C of Table 2. The mortality OR for admission to SU
is significantly lower than one for the 30 and 90 day mor-
tality in London, higher than one in Kaunas (significant for
the 90 day mortality), and as before, not significantly dif-
ferent from one for the three outcome measures in Dijon
and Florence. When we combine observations across the
four centers, adjusted OR by admission to SU or GMW
are fairly similar in Panel B and Panel C. In each case the
combined OR is not significantly different from one, but
this is to be expected since, (1) it ignores the differences
in these centers and (2) because the lower than one OR
for London is combined with the higher than one OR in
Kaunas, such that the average effect is much closer to one.
Based on these adjusted ORs by center, a tentative
conclusion is that patients admitted to SU in London
have better survival probabilities than their counterparts
admitted to GMW, at least in the short and intermediate
term (30 and 90 days). Similarly, patients admitted to SU
in Kaunas tend to fare much worse when admitted to SU,
at least in the intermediate and the long run (90 and one
year mortality) while patients in Dijon and Florence are at
par in terms of survival in SU and GMW.
However, these results are driven in part by the type
of patient admitted to SU or GMW. The bottom part of
Table 2 (Panel D) provides the adjusted OR for admis-
sion to SU by the initial severity of stroke as measured
by Glasgow Coma Scale (GCS) or the National Institutes
of Health Stroke Scale (NIHSS). The GCS ranges from
3-15 and a higher value of GCS indicates a less severe
stroke whereas the NIHSS ranges from 0-42, with higher
values reflecting more severe case. Controlling for other
factors, a one point increase in GCS is associated
with a 17% increase in odds of admission to SU in London,
a 13% decrease in odds of admission to SU in Kaunas,
a 7% increase in odds of admission to SU in Dijon, and
an 11% decrease in odds of admission to SU in Florence.
Of these, the OR for London and Kaunas are significant
while Dijon and Florence are not. Patients with less severe
stroke are more likely to be admitted to SU in London
while those with more severe stroke are more likely to be
admitted to SU in Kaunas and there is no statistical evi-
dence at conventional significance levels to suggest that
initial severity of stroke plays a significant role in admis-
sion to SU or GMW in Dijon and Florence (though for
Florence, which had the least number of observations, the
p-value is 0.16). Repeating the analysis with NIHSS shows
a similar selection process. A one point increase in NIHSS
value decreases the odds of admission to SU in London
by 7%, increases the odds of admission by 22% in Kaunas,
decreases it by 10% in Dijon and increases it by 9% in
Florence and the OR is significantly different from one
even for Dijon.
Propensity score analysis
Patients admitted to SU and GMW may differ in other
characteristics as well. Table 3 lists the differences in
means, along with the associated p-values, for the differ-
ence for each of the covariates by SU and GMW (under
the columns labeled ‘Pre’). In London, on average, patients
admitted to SU score two points higher on GCS score
and are 12% less likely to fail the swallow test at admis-
sion. Some differences also exist on the type of stroke and
pre-existing co-morbidity of hypertension. By contrast,
patients admitted to SU in Kaunas are very different. On
average, the SU patients score two and half points lower
on the GCS score, are 12% more likely to fail the swal-
low test, SU patients are 9.9 years older and about 16.8%
also suffer from atrial fibrillation, a known risk factor for
stroke. In Dijon and Florence there is no significant differ-
ence in the GCS score among patients admitted to SU or
GMW. However, those admitted to SU in Dijon are 18.5%
less likely to fail the initial swallow test and are almost
four and a half years younger, while in Florence only age
appears to be significant and only at the 10% significance
level.
To adjust for these differences in observables, a propen-
sity score for each patient was computed as the logit
predicted probability of admission to SU. All the original
covariates, along with the interactions among the covari-
ates that were initially significantly different were used
to predict the probability of admission to SU. Weighting
observations based on the propensity score, the differ-
ences in covariates were no longer significant and are
given in the columns labeled ‘Post’ in Table 3. The results
show that a good balance was achieved so that outcomes
can be analyzed conditional on this score.
The odds ratios based on the two propensity score
methods described earlier are given in Table 4. Two things
are worth pointing out about odds ratios listed in this
table. First, compared to the odds ratios listed earlier
using multivariate logits, the odds ratios for London have
increased in magnitude and are closer to one while for
Kaunas they have decreased in magnitude and are again
closer to one. For Florence, they have also decreased
(and are closer to one) and only for Dijon, they have
increased slightly from there original estimates and are
further away from one. These changes in the magni-
tude of the odds ratios, particularly in the direction they
have moved, show that the traditional multivariate logit
methods do not adequately account for the differences in
patient characteristics/case-mix when the underlying dis-
tributions are very different across the patients admitted
to SU and GMW. Second, except for the odds ratio for 90
and 365 days mortality in Kaunas, none of the other point
estimates are significantly different from one.
It is also worth comparing these ORs with those from
randomized control trials. The most recent Cochrane
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review (a meta analysis) compares death by the end of
scheduled follow-up (typically a year) for patients admit-
ted to comprehensive stroke wards versus general medical
ward from 11 randomized control trials [16], [see pp. 75].
The ORs in these RCTs range from as low as 0.11 to
as high as 1.50 with the mean value of 0.77 (95% CI
0.63 to 0.93). While there is large variation in these RCT
results, to the extent that the average can be used as
a ‘benchmark’, the ORs from the two propensity scores
methods for 365 days mortality for London (0.72 or 0.74)
and Dijon (0.70 or 0.76) compare well with this RCT aver-
age. Even the OR for Florence, with its large confidence
interval due to the small sample size, includes the RCT
average. Only Kaunas, which admits significantly sicker
patients to SU seems to be an outlier. By comparison, the
OR for 356 days for London from the earlier multivariate
logit method (0.55 or 0.40, see panel B or C from Table 2)
is much below the RCT average of 0.77 but the ORs from
Dijon (0.80 or 0.84) stay close to both the PSM values and
the RCT average. Recall however that London exhibited
a selection bias (less severe stroke patients admitted to
SU) while Dijon does not show similar selection bias. To
the extent that the multivariate logits and the PSM used
the same control variables, this comparison with RCTs
also shows that in observational studies PSMmethods can
better account for overt selection.
Robustness
We re-estimated the models using alternative functional
forms or measures of stroke severity. The results were
robust to other specifications such as the inclusion of
quadratic and cubic terms of the GCS score, switching to
categorical classification for the GCS as low <9, medium
10–12, and high >13, or alternatively to use individual
components of GCS for eye opening score, motor
response score, and verbal response score. Other changes
in the specifications included replacing GCS with the
Barthel score post initial stroke, omitting the swallowing
test variable, dropping additional control variables (hyper-
tension, myocardial infraction and medication therapy),
and including observations on patients with subarachnoid
haemorrhage in the analysis. In each of the cases above,
the point estimates for the earlier reported odds ratios
were only slightly different, but in none of the cases did
the results change in any substantial way.
Limitations
The odds ratios reported in this paper should not be taken
at face value for at least two reasons. First, propensity
score methods are best applicable in large data sets. In
the current analysis, the total sample is sub grouped by
cities to account for the underlying differences in care
between cities. This leads to relatively small sub samples,
especially for Florence, and hence the large confidence
intervals for odds ratios could also be attributed to a
small sample problems (albeit the same small samples
are used in both methods). Second, while the propensity
score method accounts for overt selection, the underlying
assumption is of strongly ignorable treatment assignment
given the observed covariates. The assumption implies
that no systematic unobserved pretreatment differences
exist between the two groups that are related to the out-
come measure. Nonetheless, patients who appear similar
in terms of observed covariates may differ in other impor-
tant dimensions not observed in the data. Thus, if in
addition there is a hidden (or covert) bias, neither the
multivariate regressions nor any of the propensity score
methods can produce unbiased estimates of relative effec-
tiveness of admission to stroke unit. To do so would
require finding and using an instrumental variable that
predicts reasonably well which patient is admitted to SU
or GMW, but at the same time cannot predict the prob-
ability of death or poor outcome for the patient. Such a
variable is not available in the EROS database but future
work using other databases may be able to overcome this
difficulty.
Conclusions
Benefits of organized stroke care have been debated for
the past three decades [17-19]. Randomized control trials,
as well as meta analysis of randomized trials have typi-
cally shown benefits to patients admitted to stroke units
over general wards and have formed the foundation of evi-
dence based stroke care since the mid 1990’s [16,20,21].
Since controlled trials are often conducted under special
conditions and exclude certain populations, the general
findings that patients in stroke unit are more likely to
survive, return home and regain independence are sub-
ject to criticism that these special conditions do not
apply in real settings [22,23]. As a response, researchers
have also compared outcomes between stroke units and
other wards in observational studies and reported mixed
findings [22,24,25]. Gompertz et al. [22] found that out-
comes did not differ across patients admitted to adjacent
districts in London where one had no special stroke ser-
vices while the other had comprehensive stroke services.
Using data from Swedish National Registry, Stegmayar
et al. [24] report that stroke care was effective while Terent
et al. [25], who also use data from Sweden, find that the
magnitude of benefits from admission to stroke unit is
smaller than that reported in randomized trials. They also
report that there was no difference in outcomes between
stroke unit and other wards if the patient had impaired
consciousness at admission. Nonetheless, a recent meta
analysis of observational studies [23] concluded that the
observed benefits of admission to stroke unit are compa-
rable to those reported in clinical trials but as was noted in
the review as well as elsewhere [26], there were a number
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of limitations in the study including, importantly, pos-
sible selective admission to stroke units and incomplete
case-mix adjustments.
The foregoing analysis shows that traditional multi-
variate regression based methods tend to overestimate
the impact of admission to stroke unit on outcomes in
the presence of overt selection. When there is favorable
selection of patients, e.g. London, the odds ratios are
downward biased. When there is unfavorable selection,
e.g., Kaunas, the odds ratios are upward biased. In both
London and Kaunas, where selection is most severe, odds
ratios based on multivariate logits are significantly below
or above one. Correcting explicitly for this imbalance in
covariate distribution, especially for the severity of stroke,
leads to a much more modest impact of stroke unit on
patient mortality. In the case of London, there is no statis-
tical difference in mortality between SU and GMW. In the
case of Kaunas, the mortality rates are higher in SU and
the intermediate and long term (90 and 365 days) odds
ratio stay significantly above one, though the magnitude
decreases once selection of more severe and older patients
in SU is accounted for via propensity scores. In the case of
the other two cities, Dijon and Florence, where the distri-
bution of severity is more balanced, the conclusions from
the two methods, multivariate regressions and propen-
sity score methods do not change, i.e., admission to stroke
unit does not lead to statistically different outcomes as the
confidence interval for the odds ratios always include one.
Our analysis does not support the hypothesis that
admission to SU leads to lower mortality compared to
patients admitted to GMW. The lower odds of death in SU
in London are driven by selection of patients with lower
initial severity of stroke while the higher odds of death in
SU in Kaunas are driven, in part, by selection of patients
with greater initial severity of stroke. The other two cen-
ters exhibit neither any significant selection by severity of
stroke, nor do they, consequently, show an difference in
outcomes by SU or GMWwards.
The different estimates of odds ratios presented in this
paper highlight that alternative conclusions about the
relative effectiveness of stroke units can be drawn depend-
ing on if overt selection is accounted for or not in the
estimation methods. Moreover, these estimates show that
the case for cost-effectiveness of stroke units, compared
to care in other wards is not a closed case (even the ear-
lier cited RCTs show ORs ranging from .11 to 1.50). For
instance, Patel et al. compared outcomes and costs from
a randomized control trial where patients either received
care in a stroke unit, in the care of a stroke team (in
other wards) or in domiciliary care [27]. While the per-
centage of patients who avoided death or institualization
at one year was 87% in stroke unit, 69% in stroke team and
78% in domiciliary care respectively, the stroke care unit
was most expensive while domiciliary care the cheapest.
At a willingness to pay of £30,000 per additional QALY,
the probability that the stroke unit or stroke team are the
most optimal of the three strategies was only 29% and
the incremental cost effectiveness ratio (ICER) between
stroke unit and domiciliary care ranged from £67K to
£137K (depending on the cost perspective used). Similarly,
the reported ICER of £10,661 of SU compared to general
medical ward in Saka et al. [28] is based on cost estimates
from observational data from South London but effective-
ness measures from an earlier randomized trial [29] of
conventional care compared with an early discharge pol-
icy at two hospitals in the same area. In either of these
studies, the ICER figures are likely to bemuch higher if the
incremental effectiveness in these ratios is replaced with
figures computed from observational studies that account
for the selection bias.
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